User profiles for Markku Laakso
Markku LaaksoProfessor of Internal Medicine, University of Eastern Finland Verified email at uef.fi Cited by 276321 |
Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans
…, K Punnonen, J Kuusisto, H Gylling, M Laakso - Journal of …, 2012 - Elsevier
BACKGROUND & AIMS: Mechanisms leading to non-alcoholic steatohepatitis (NASH) have
remained unclear, and non-invasive diagnosis of NASH is challenging. In this study, we …
remained unclear, and non-invasive diagnosis of NASH is challenging. In this study, we …
Adiponectin gene haplotype is associated with preeclampsia
…, M Hiltunen, S Helisalmi, S Heinonen, M Laakso - Genetic …, 2006 - liebertpub.com
We determined whether the polymorphism of the gene encoding adiponectin contributes to
susceptibility to preeclampsia. The study involved 133 Finnish women with preeclampsia …
susceptibility to preeclampsia. The study involved 133 Finnish women with preeclampsia …
The Ala54Thr polymorphism of the fatty acid binding protein 2 gene does not influence insulin sensitivity in Finnish nondiabetic and NIDDM subjects
…, S Heikkinen, P Kekäläinen, J Kuusisto, M Laakso - Diabetes, 1997 - Am Diabetes Assoc
Insulin resistance and hyperinsulinemia are major predictors of NIDDM. Since several
studies have demonstrated that heredity plays a significant role in the development of insulin …
studies have demonstrated that heredity plays a significant role in the development of insulin …
† Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text‡: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of …
…, F Cosentino, B Jönsson, M Laakso… - European heart …, 2007 - academic.oup.com
… Markku Laakso … Lars Rydén, Eberhard Standl, Małgorzata Bartnik, Greet Van den
Berghe, John Betteridge, Menko-Jan de Boer, Francesco Cosentino, Bengt Jönsson …
Berghe, John Betteridge, Menko-Jan de Boer, Francesco Cosentino, Bengt Jönsson …
Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis …
…, A Rantala, K Peuhkurinen, MS Nieminen, M Laakso… - Circulation, 2003 - Am Heart Assoc
Background— Catheter-based intracoronary vascular endothelial growth factor (VEGF) gene
transfer is a potential treatment for coronary heart disease. However, only limited data are …
transfer is a potential treatment for coronary heart disease. However, only limited data are …
How good a marker is insulin level for insulin resistance?
M Laakso - American journal of epidemiology, 1993 - academic.oup.com
… Markku Laakso … (Reprint requests to Dr Markku Laakso at this address) This work was
supported by a grant from the Academy of Finland. … 960 Laakso …
supported by a grant from the Academy of Finland. … 960 Laakso …
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Background The worldwide increase in type 2 diabetes mellitus is becoming a major health
concern. We aimed to assess the effect of acarbose in preventing or delaying conversion of …
concern. We aimed to assess the effect of acarbose in preventing or delaying conversion of …
[HTML][HTML] Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
…, T Rönnemaa, K Pyörälä, M Laakso - New England journal …, 1998 - Mass Medical Soc
Background Type 2 (non-insulin-dependent) diabetes is associated with a marked increase
in the risk of coronary heart disease. It has been debated whether patients with diabetes …
in the risk of coronary heart disease. It has been debated whether patients with diabetes …
[HTML][HTML] Analysis of protein-coding genetic variation in 60,706 humans
Large-scale reference data sets of human genetic variation are critical for the medical and
functional interpretation of DNA sequence changes. Here we describe the aggregation and …
functional interpretation of DNA sequence changes. Here we describe the aggregation and …
“Effective” number of parties: a measure with application to West Europe
M Laakso, R Taagepera - Comparative political studies, 1979 - journals.sagepub.com
Before this question can be answered, the number of parties must be operationally defined
in a way that takes into account their relativesize. Such a number is also needed if one wants …
in a way that takes into account their relativesize. Such a number is also needed if one wants …